Tumor necrosis factor in children with malignancies

Area of Science:

• Pediatric Oncology
• Immunology
• Biochemistry

Background:

• Malignancies in children are a significant health concern.
• Tumor necrosis factor alpha (TNF) is a cytokine with known roles in inflammation and immunity.
• The role of TNF in pediatric cancers requires further elucidation.

Purpose of the Study:

• To measure serum TNF concentrations in children with various malignancies.
• To assess the correlation between TNF levels and disease status (diagnosis vs. remission).
• To determine the potential diagnostic and prognostic value of serum TNF in pediatric cancers.

Main Methods:

• Serum samples were collected from 32 children diagnosed with malignancies (acute lymphoblastic leukemia, acute nonlymphocytic leukemia, solid tumors).
• Serum TNF-alpha concentrations were quantified using a sensitive double-antibody radioimmunoassay.
• Levels were compared between patients at diagnosis, patients in remission, and a reference group of healthy children.

Main Results:

• 30 out of 32 pediatric cancer patients exhibited elevated serum TNF levels at diagnosis (up to 450 ng/liter).
• Following achievement of complete remission (2-6 months post-diagnosis), TNF levels decreased significantly, falling within the normal range.
• The established upper limit of normal for serum TNF was determined to be 40 ng/liter, with most healthy children below the detection limit.

Conclusions:

• Elevated serum TNF concentrations are strongly associated with the presence of malignancies in children.
• Serum TNF levels appear to be a valuable biomarker for monitoring treatment response and disease remission.
• Further research into TNF's role could enhance diagnostic and follow-up strategies for pediatric cancers.